In Yo-PCD ovarian carcinomas, a high percentage of the tumors were found to harbor at least one genetic alteration of Yo antigens which was not observed in ovarian carcinoma samples extracted from patients without Yo-PCD (120). Here, CDR2 is linked to paraneoplastic neurologic syndrome.